Search Orphan Drug Designations and Approvals
-
Generic Name: | human recombinant bone morphogenetic protein 4 |
---|---|
Date Designated: | 05/04/2016 |
Orphan Designation: | Treatment of glioblastoma multiforme. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Stemgen Spa Piazza della Scienza, 2 Milano 20 126 Italy The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-